492 related articles for article (PubMed ID: 9625400)
1. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
2. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
3. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
4. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
Zhang J; Yu C; Noonan G; Reiss TF
Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
[TBL] [Abstract][Full Text] [Related]
5. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
Knorr B; Matz J; Bernstein JA; Nguyen H; Seidenberg BC; Reiss TF; Becker A
JAMA; 1998 Apr; 279(15):1181-6. PubMed ID: 9555757
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
[TBL] [Abstract][Full Text] [Related]
7. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
[TBL] [Abstract][Full Text] [Related]
8. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
Noonan MJ; Chervinsky P; Brandon M; Zhang J; Kundu S; McBurney J; Reiss TF
Eur Respir J; 1998 Jun; 11(6):1232-9. PubMed ID: 9657560
[TBL] [Abstract][Full Text] [Related]
9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
10. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
11. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
[TBL] [Abstract][Full Text] [Related]
13. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
[TBL] [Abstract][Full Text] [Related]
14. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on montelukast in asthma in children 2 to 14 years of age.
Muijsers RB; Noble S
Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
[TBL] [Abstract][Full Text] [Related]
16. Montelukast: a review of its therapeutic potential in persistent asthma.
Jarvis B; Markham A
Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
[TBL] [Abstract][Full Text] [Related]
18. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
Baumgartner RA; Martinez G; Edelman JM; Rodriguez Gomez GG; Bernstein M; Bird S; Angner R; Polis A; Dass SB; Lu S; Reiss TF;
Eur Respir J; 2003 Jan; 21(1):123-8. PubMed ID: 12570120
[TBL] [Abstract][Full Text] [Related]
19. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.
Löfdahl CG; Reiss TF; Leff JA; Israel E; Noonan MJ; Finn AF; Seidenberg BC; Capizzi T; Kundu S; Godard P
BMJ; 1999 Jul; 319(7202):87-90. PubMed ID: 10398629
[TBL] [Abstract][Full Text] [Related]
20. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
